Clinical and dosimetric variables related to outcome after treatment of Graves’ Disease with 550 and 1110 mbq of 131I: Results of a prospective randomized trial - Sapienza, M T; Coura-Filho, G B; Willegaignon, J (Clin Nucl Med, 2015)
et al.